Lee, Yuan-Ju
Chang, Shang-Jen
Lin, Hsiu-Ying
Meng, En
Chueh, Jeff S.
Tseng, Chi-Shin
Article History
Received: 1 April 2022
Accepted: 22 September 2022
First Online: 6 October 2022
Competing interests
: The authors declared that they have no competing interests. The intervention drugs of oral PPS (UrosanĀ®) was sponsored by TCM Biotech International Corporation (Taipei, Taiwan).